Amid the global COVID-19 outbreak, many countries are trying to provide equitable, good quality, and cost-effective healthcare services. Value-based health care (VBHC), which aims to improve healthcare services by increasing outcomes with lowered costs, bas been in the spotlight against volume-based healthcare delivery systems such as fee-for-service payment models. The Asia Pacific region is no exception in this global trend of VBHC and the concept of VBHC is rapidly spreading and various demonstrations (e.g., value-based payment, value-based pricing, or value-based procurement, etc.) are being undertaken and more discussion to adopt this value-based approach is underway. There has been divergent operation of VBHC across the Asia Pacific region such as the VBHC arrangements limited to specific technologies (e.g., pharmaceuticals, medical devices, and diagnostics) or comprehensive healthcare delivery transformation to embrace VBHC throughout the healthcare system. In addition, there are some countries that still focus on volume-based payment rather than value as their main theme in payment models.

This session will address the snapshot of VBHC operation across the Asia Pacific region and discuss about the health policy aligned with VBHC in the areas of reimbursement, pricing, and payment models, as well as opportunities and challenges to implement VBHC to help build sustainable and resilient healthcare systems.